Earth Science Tech, Inc. (OTC: ETST) announced its fiscal first-quarter 2027 financial results, revealing a 57% year-over-year increase in net income to $715,697. The company's revenue reached $9.0 million, a 3% rise from the prior-year period, while gross profit climbed to $6.3 million. Operating cash flow more than doubled to $707,131, and total assets grew to $10.4 million. Diluted earnings per share improved to $0.003 from $0.001.
The company also reported that it repurchased and retired more than 3.7 million common shares during the quarter without adding debt. This move underscores management's confidence in the company's financial position and commitment to enhancing shareholder value. All key operating subsidiaries remained profitable, according to the company.
Earth Science Tech continues to expand the licensing footprint of its compounding pharmacy operations across the United States. The company is also evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms. These strategic initiatives are part of its broader vision to build a vertically integrated healthcare platform that seamlessly integrates patient care from consultation to fulfillment.
Management will discuss these results and strategic initiatives at the annual shareholder meeting scheduled for Aug. 31, 2026. Investors will vote on proposals including the cancellation of the company's Series B Preferred Stock and will hear updates on a potential exchange uplisting aimed at improving liquidity and market visibility.
The company's performance reflects its diversified holding company model, which combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. This approach is supported by investments in real estate and asset management activities and a consumer products business.
For more information, visit the company's newsroom at https://ibn.fm/ETST.
